Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Cash (2020 - 2025)

PROCEPT BioRobotics has reported Change in Cash over the past 6 years, most recently at -$7.8 million for Q4 2025.

  • Quarterly results put Change in Cash at -$7.8 million for Q4 2025, down 105.68% from a year ago — trailing twelve months through Dec 2025 was -$47.2 million (down 161.73% YoY), and the annual figure for FY2025 was -$47.2 million, down 161.73%.
  • Change in Cash for Q4 2025 was -$7.8 million at PROCEPT BioRobotics, up from -$8.4 million in the prior quarter.
  • Over the last five years, Change in Cash for PRCT hit a ceiling of $161.3 million in Q3 2021 and a floor of -$40.9 million in Q1 2023.
  • Median Change in Cash over the past 5 years was -$15.3 million (2021), compared with a mean of $9.4 million.
  • Peak annual rise in Change in Cash hit 767.36% in 2023, while the deepest fall reached 140.58% in 2023.
  • PROCEPT BioRobotics' Change in Cash stood at -$16.2 million in 2021, then tumbled by 69.25% to -$27.4 million in 2022, then decreased by 12.0% to -$30.6 million in 2023, then surged by 546.98% to $137.0 million in 2024, then crashed by 105.68% to -$7.8 million in 2025.
  • The last three reported values for Change in Cash were -$7.8 million (Q4 2025), -$8.4 million (Q3 2025), and -$13.5 million (Q2 2025) per Business Quant data.